PMC:3724972 / 24312-24807 JSONTXT

{"project":"2_test","denotations":[{"id":"23673515-22851491-63233672","span":{"begin":491,"end":493},"obj":"22851491"}],"text":"A recent small study showed a marked reduction in UFC levels in 5/7 patients (22–73 % of baseline values), and UFC normalization in three patients. There was no apparent pattern of decrease in plasma cortisol. Plasma ACTH decreased in the first month of treatment and then returned to pretreatment levels in responsive patients. Blood pressure, glycemia, and signs of hypercortisolism improved on treatment. Patients reported only mild adverse effects (e.g., xerophthalmia and arthralgias) [59]."}